Physician profile
Michael Williams
NPI 1225410236
$5,526.49
in general payments reported to CMS, 2019-2025
13 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $15.44 · 2021: $2,620 · 2022: $2,361 · 2023: $196 · 2024: $22.99 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,239.97 | 2022 | |
| Medtronic, INC. | $1,987.65 | 2021 | |
| Terumo Medical Corporation | $632.11 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.75 | 2019 | |
| Abbott Laboratories | $121.29 | 2022 | |
| Edwards Lifesciences Corporation | $113.98 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $112.68 | 2025 | |
| Scpharmaceuticals INC. | $32.70 | 2023 | |
| Olympus America INC. | $26.87 | 2019-2020 | |
| Shockwave Medical, INC | $26.09 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $23.54 | 2023 | Assure Wcd |
| Philips North America LLC | $22.99 | 2024 | (Bq9) Coronary Ivus |
| Boston Scientific Corporation | $13.87 | 2025 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.